The protocol describes a tandem immunofluorescence hybridization assay with formalin-fixed paraffin-embedded tissue to detect and quantify microRNA and multiplexed proteins simultaneously.
Method Article
The protocol describes a tandem immunofluorescence hybridization assay with formalin-fixed paraffin-embedded tissue to detect and quantify microRNA and multiplexed proteins simultaneously.
When using traditional probe-based in situ hybridization (ISH) imaging detection methods, microRNAs (miRNAs) are difficult to capture due to their size, which ranges from 19 to 25 nucleotides. However, as miRNAs are key epigenetic regulators that contribute to normal physiology and numerous pathological conditions, understanding the spatiotemporal behavior of miRNAs is important to unravel their function at the cellular and subcellular levels. This creates a clear need for adequate detection and visualization techniques. Therefore, we created MicroRNA Amplification and Recognition through Locked-nucleic-acid in situ hybridizatioN (MARLIN), which was developed and optimized utilizing multiplex immunofluorescence staining, and locked nucleic acid (LNA) probes targeted to a miRNA. This method can quantify miRNA with multiplexed protein expression, which allows the quantification of intracellular and extracellular miRNA within the tumor microenvironment (TME) with high sensitivity and reproducibility. The combined use of miRNA detection and protein capture assays can also provide a comprehensive understanding of cellular functions and regulatory mechanisms within that TME.
microRNAs
Although microRNAs (miRNA) are incredibly small, ranging 19-25 nucleotides in length, these single-stranded RNA molecules are potent regulators in gene expression, modulating messenger RNAs (mRNAs) post-transcriptionally through sequence-specific interactions1. In essence, miRNAs act as negative regulators by binding to target mRNAs, either preventing their translation or promoting their degradation through mRNA cleavage, depending on the degree of complementarity, which ultimately leads to decreased protein output from the targeted gene. While miRNAs are basically non-coding RNA, approximately 40% of all miRNAs....
Access restricted. Please log in or start a trial to view this content.
This protocol uses formalin-fixed paraffin-embedded (FFPE) tissues of human ovarian tumor tissue sections from patients with HGSC. These samples were collected from previously untreated patients undergoing primary cytoreductive surgery for ovarian cancer. All samples and clinical data were obtained from the ovarian cancer repository of the Department of Gynecologic Oncology and Reproductive Medicine under protocols approved by the University of Texas MD Anderson's Institutional Review Board. Written informed consent from the patients was obtained by front desk personnel, and the studies were conducted in accordance with recognized ethical guidelines.
Access restricted. Please log in or start a trial to view this content.
When testing this protocol, it is important to have two serial sections of the same representative sample for accuracy and comparison. In this case, a High-Grade Ovarian Cancer (HGSC) sample was used to compare the results. A control slide (Figure 2A-B) that would only go through the miRNA staining and a test slide that would undergo both protein and miRNA staining (Figure 2C-J) were used.
Access restricted. Please log in or start a trial to view this content.
Though the importance of miRNAs is recognized and understood, observations of both normal development and disease states are currently hindered by the difficulty of studying miRNAs using standard methods. The scarcity of in situ methods led to the development of MARLIN (miRNA FISH assay). Given the homology and short length of miRNAs, it becomes a challenge to visualize their location and effect on post-transcriptomic regulation. This protocol development utilizes Locked Nucleic Acid Probes (LNA). LNAs are modif.......
Access restricted. Please log in or start a trial to view this content.
The authors have nothing to disclose.
We would like to acknowledge the following people, Chi Lam Au Yeung and Manjunath Nimmakayalu, who were a part of Basant's thesis committee while the assay was in development. Also, Samuel Mok, who sectioned and provided the samples used. Lastly, we acknowledge Johan Doré and Dan Winkowski, who provided extensive assistance during analysis and the use of the Visiopharm software. This research was funded in part by the Ovarian Cancer Research Alliance (OCRA 811621 and 891490), the Sie Foundation, and the Stephanie C. Stelter Endowment Fund. This research was performed in collaboration with the Flow Cytometry and Cellular Imaging Core Facility, which is support....
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 10x TRIS-buffered Saline (TBS) pH 7.6 | Thermo Fisher Scientific | J62662 K7 | For intermittent washes between steps |
| 1x Opal Antibody Diluent/Block | Akoya Biosciences | ARD1001EA | Protein blocking solution |
| 1x Plus Automation Amplification Diluent | Akoya Biosciences | FP1609 | Used to dilute Opal fluorophores |
| 20x Concentrate Saline Sodium Citrate (SSC) Buffer | Sigma-Aldrich | S6639-1L | For miRNA washes after probe hybridization |
| 4',6-diamidino-2-phenylindole (DAPI) | Thermo Fisher Scientific/ Invitrogen | EN62248 / 62248 | For nuclear staining |
| ACD HybEZ II Hybridization System | ACD Biotechne | 321711 | Oven used to regulate temperature during miRNAscope protocol |
| Anti-CD8 (D8A8Y), Rabbit mAb | Cell Signaling Technologies | 85336S | Example of primary antibody used to optimize this protocol |
| Anti-Digoxigenin (Mouse) HRP Conjugate | Revvity Health Sciences Inc | NEF832001EA | Secondary reagent used for miRNA detection |
| Anti-EpCAM (E6V8Y), Rabbit mAb | Cell Signaling Technologies | 93790 | Example of primary antibody used to optimize this protocol |
| Blocking Reagent Powder | Akoya Biosciences | FP1012 | miRNA blocking solution |
| Ethyl Alcohol 100% (200 Proof) | Pharmco | 111000200 | For deparaffinization |
| EZ-AR1 Buffer | BioGeneX | HK521-XAK | Used for antigen retrieval of FFPE tissue sections at the protein step |
| EZ-AR1 Elegance Buffer | BioGeneX | HK546-XAK | Used for antigen retrieval of FFPE tissue sections at the miRNA probe step |
| EZ-Retriever IR System | BioGeneX | MW015-IR | Microwave used for antigen retrieval of FFPE tissue sections |
| Hydrogen Peroxide Solution 30% | Sigma-Aldrich | HX0640-5 | For Tissue preparation. Helps to block endogenous peroxidase activity and to yield highly colored products |
| miR-181c-3p miRNA Probe | Qiagen | 339112 | Example of miRNA probe used to optimize this protocol |
| miRCURY LNA miRNA ISH Buffer Set (FFPE) | Qiagen | 339450 | Used to dilute miRNA probe |
| Opal 620 | Akoya Biosciences | FP1495001KT | Fluorophore to identify primary antibody |
| Opal 690 | Akoya Biosciences | FP1497001KT | Fluorophore to identify primary antibody |
| Opal Anti-Ms + Rb HRP | Akoya Biosciences | ARH1001EA | Secondary antibody used as a detection agent |
| Pierce 16% Formaldehyde (w/v), Methanol-free | Thermo Fisher Scientific | 28908 | To make 3.7% PFA for tissue preparation |
| ProLong Diamond Antifade | Thermo Fisher Scientific | P36970 | Mounting media |
| RNAscope Protease Plus | ACD Biotechne | 322331 | To permeabilize tissue sections by partially digesting proteins & expose target miRNA molecules |
| RNAse-free water | Corning | 46-000-CM | To clean and prep all equipment, and to use as a dilutant when necessary |
| Tween 20 | Sigma-Aldrich | P1379-25ML | To make TBS-T |
| Tyramide Signal Amplification Plus Cyanine 3 | Akoya Biosciences | NEL744001KT | Fluorophore to identify miRNA |
| U6 and Scramble miRNA Probes | Qiagen | 339459 | Optional control probes |
| Xylenes Histological Grade | Thermo Fisher Scientific | UN1307 | For deparaffinization |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission